POSOCCO, BIANCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.432
AS - Asia 2.012
EU - Europa 814
SA - Sud America 303
AF - Africa 273
Continente sconosciuto - Info sul continente non disponibili 42
OC - Oceania 21
Totale 5.897
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.226
SG - Singapore 605
VN - Vietnam 470
CN - Cina 324
IT - Italia 197
BR - Brasile 196
HK - Hong Kong 146
BD - Bangladesh 125
DE - Germania 105
FI - Finlandia 77
CA - Canada 54
FR - Francia 53
GB - Regno Unito 46
IN - India 46
PL - Polonia 39
RU - Federazione Russa 36
TR - Turchia 27
NL - Olanda 24
AR - Argentina 23
PK - Pakistan 22
ZA - Sudafrica 22
MX - Messico 19
UA - Ucraina 19
EC - Ecuador 18
SA - Arabia Saudita 18
AT - Austria 17
CO - Colombia 17
JP - Giappone 17
IQ - Iraq 16
KR - Corea 16
ID - Indonesia 15
PY - Paraguay 15
SE - Svezia 15
HN - Honduras 14
GE - Georgia 13
MA - Marocco 13
CL - Cile 12
DK - Danimarca 12
GT - Guatemala 12
NI - Nicaragua 12
BJ - Benin 11
EG - Egitto 11
BB - Barbados 10
CR - Costa Rica 10
HR - Croazia 10
KG - Kirghizistan 10
RO - Romania 10
AL - Albania 9
AO - Angola 9
IE - Irlanda 9
JO - Giordania 9
LV - Lettonia 9
ML - Mali 9
SN - Senegal 9
TH - Thailandia 9
YT - Mayotte 9
AD - Andorra 8
BA - Bosnia-Erzegovina 8
CV - Capo Verde 8
ES - Italia 8
GN - Guinea 8
LA - Repubblica Popolare Democratica del Laos 8
MG - Madagascar 8
MY - Malesia 8
NP - Nepal 8
PH - Filippine 8
PT - Portogallo 8
RE - Reunion 8
TT - Trinidad e Tobago 8
BF - Burkina Faso 7
BY - Bielorussia 7
CG - Congo 7
CI - Costa d'Avorio 7
CW - ???statistics.table.value.countryCode.CW??? 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
GM - Gambi 7
IL - Israele 7
JM - Giamaica 7
LU - Lussemburgo 7
MD - Moldavia 7
PS - Palestinian Territory 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
BZ - Belize 6
CZ - Repubblica Ceca 6
EE - Estonia 6
ET - Etiopia 6
GP - Guadalupe 6
GR - Grecia 6
IR - Iran 6
KE - Kenya 6
LC - Santa Lucia 6
LT - Lituania 6
LY - Libia 6
MK - Macedonia 6
MN - Mongolia 6
MR - Mauritania 6
NA - Namibia 6
NZ - Nuova Zelanda 6
Totale 5.610
Salva come PNG Salva come JPEG
Città #
Ashburn 439
Singapore 411
San Jose 366
Ho Chi Minh City 155
Hanoi 137
Hong Kong 134
Fairfield 104
Santa Clara 94
Beijing 85
Chandler 85
Munich 68
Council Bluffs 63
New York 50
Houston 49
Los Angeles 47
Seattle 42
Cambridge 41
Ann Arbor 40
Helsinki 38
Boardman 36
Buffalo 34
Woodbridge 34
Bytom 29
Wilmington 28
Lauterbourg 27
Dallas 25
Chicago 22
Da Nang 22
São Paulo 22
Milan 21
Turku 21
San Diego 19
Montreal 16
Princeton 16
Guangzhou 15
Rome 15
Medford 14
London 13
Orem 13
Toronto 13
Haiphong 12
Hefei 12
Managua 12
Phoenix 12
Tokyo 12
Cotonou 11
Johannesburg 11
Naples 11
Bridgetown 10
Chennai 10
Vienna 10
Bishkek 9
Bến Tre 9
Falkenstein 9
Jeddah 9
Lahore 9
Amman 8
Andorra la Vella 8
Biên Hòa 8
Brooklyn 8
Cairo 8
Conakry 8
Dakar 8
Guayaquil 8
Hải Dương 8
Kyiv 8
Riga 8
Rio de Janeiro 8
Salt Lake City 8
San Francisco 8
Trieste 8
Amsterdam 7
Ankara 7
Baghdad 7
Des Moines 7
Frankfurt am Main 7
Luanda 7
Minsk 7
Padua 7
Praia 7
San José 7
Tirana 7
Abidjan 6
Baku 6
Bamako 6
Boston 6
Brazzaville 6
Castries 6
Copenhagen 6
Guatemala City 6
Jacksonville 6
Kampala 6
Kigali 6
Lappeenranta 6
Luxembourg 6
Nairobi 6
Nha Trang 6
Ninh Bình 6
Nouakchott 6
Panama City 6
Totale 3.376
Salva come PNG Salva come JPEG
Nome #
Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma 257
A new high-performance liquid chromatography–tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine 239
Cross-validation of a mass spectrometric-based method for the therapeutic drug monitoring of irinotecan: implementation of matrix-assisted laser desorption/ionization mass spectrometry in pharmacokinetic measurements 237
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer 233
NPQ activation reduces chlorophyll triplet state formation in the moss Physcomitrella patens 231
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions 217
Light driven water oxidation by a single site cobalt salophen catalyst 214
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure 213
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis 212
Analytical aspects of sunitinib and its geometric isomerism towards therapeutic drug monitoring in clinical routine 207
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 203
A LC–MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma 201
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 195
Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients 192
An SPR investigation into the therapeutic drug monitoring of the anticancer drug imatinib with selective aptamers operating in human plasma 191
Field-assisted paper spray mass spectrometry for the quantitative evaluation of imatinib levels in plasma 187
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method 186
Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations 184
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer 178
Bioanalytical Methods for Poly(ADP-Ribose) Polymerase Inhibitor Quantification: A Review for Therapeutic Drug Monitoring 177
Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series 175
A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring 175
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure 174
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring 172
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 168
Mass spectrometry in the pharmacokinetic studies of anticancer natural products 164
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring 164
Therapeutic drug monitoring of palbociclib, ribociclib and letrozole in women with breast cancer by LC-MS 161
The development of a matrix-assisted laser desorption/ionization (MALDI)-based analytical method for determination of irinotecan levels in human plasma: Preliminary results 148
A fast and validated LC-MS/MS method to quantify lenvatinib in dried blood spot 142
Matrix-assisted laser desorption/ionization, nanostructure-assisted laser desorption/ionization and carbon nanohorns in the detection of antineoplastic drugs. 1. The cases of irinotecan, sunitinib and 6-alpha-hydroxy paclitaxel 100
Totale 5.897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.316
article - articoli 17.316
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.632
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022156 0 0 13 11 4 28 10 16 9 14 15 36
2022/2023185 25 22 3 26 32 17 0 9 28 4 13 6
2023/2024122 6 16 6 11 9 27 11 6 10 3 11 6
2024/2025905 1 79 40 36 77 52 30 83 44 44 146 273
2025/20263.755 216 218 461 457 379 150 639 313 377 207 216 122
2026/2027404 132 146 126 0 0 0 0 0 0 0 0 0
Totale 5.897